Head to head
Envision vs Venus Versa Pro (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- The catalog lists $100k–$130k for Venus Versa Pro. No new-price range is on file for Envision. Check the source notes and request current quotes.
- Practice fit
- Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.
IPL multi-app platform
View full device profile →IPL multi-app platform
View full device profile →Price comparison
New price range
- InMode Envision
- Not published
- Venus Versa Pro
- $100k–$130kSource not documented
Used asking range
- InMode Envision
- Not published
- Venus Versa Pro
- Not published
Payback calculator
- InMode Envision
- View cost details
- Venus Versa Pro
- View ROI calculator
Next step
Consumable economics
Consumable cost / lock-in
- InMode Envision
- —
- Venus Versa Pro
- —
Service cost
- InMode Envision
- Not published
- Venus Versa Pro
- Not published
FDA clearance
FDA status & indication
- InMode Envision
Read FDA indication wording
“The InMode Multi System with the Diode laser Applicators is indicated for: • Diolaze XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. • Diolaze XL 755/810nm & 810/1064nm Applicators are intended for hair removal. • VLaze Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The InMode Multi System with the IPL Applicator is indicated for: • IPL Applicator with wavelengths (515-1200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations. The InMode Multi System with the non-invasive RF Applicators is indicated for: • BodyFX (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite. • PLUS/ PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation. • FaceFX (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids. The InMode Multi System with the Fractional RF Applicators is indicated for: • FRACTORA 60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin. • FRF 24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. • Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.”
- Venus Versa Pro
- FDA ClearedK232192
Read FDA indication wording
“The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”
Which chains run each
Chain adoption
- InMode Envision
- 0 recorded pairings
- Venus Versa Pro
- 0 recorded pairings
Chains using it
- InMode Envision
- —
- Venus Versa Pro
- —
Approved reviews
- InMode Envision
- 0
- Venus Versa Pro
- 0
Specs and platform
Manufacturer
- InMode Envision
- InMode
- Venus Versa Pro
- Venus Concept
Built by (OEM)
- InMode Envision
- —
- Venus Versa Pro
- Venus Concept Inc.
Category
- InMode Envision
- IPL multi-app platform
- Venus Versa Pro
- IPL multi-app platform
Technology
- InMode Envision
- —
- Venus Versa Pro
- Updated IPL/HR multi-app (IPL)
Launch year
- InMode Envision
- —
- Venus Versa Pro
- 2023
Status
- InMode Envision
- Current
- Venus Versa Pro
- Current
Manufacturer source record
- InMode Envision
- No linked source on file.
- Venus Versa Pro
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.